Coya Therapeutics logo

Coya Therapeutics

Coya Therapeutics develops treatments that target regulatory T cells, or Tregs, to treat Alzheimer's and ALS.

2

Funding Rounds

$30.0m

Money raised

Overview

Coya Therapeutics develops treatments that target regulatory T cells, or Tregs, to treat Alzheimer's and ALS.